Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Infographics
Neurology
14 Jun 2024
Erratum: Ozanimod Long-Term Safety and Efficacy
In the infographic published under AMJ Neurology, on 30th May 2024, the graphs depicting safety over time titled ‘Malignancy TEAEs’…
Neurology
30 May 2024
Ozanimod Long-Term Safety and Efficacy
S1P receptor 1 and 5 modulator for relapsing forms of MS in adults, including clinically isolated syndrome, relapsing-remitting disease…
Dermatology
12 Apr 2024
JAK Inhibitors for Alopecia Areata
Exploring the promise of Janus kinase inhibitors (JAKi) in treating alopecia areata (AA), this infographic outlines the mechanism of…
Hematology
25 Mar 2026
The History of Von Willebrand Disease
The first case of VWD was described and published in 1926 by Erik von Willebrand. Therefore, 2026 marks its centenary anniversary…
Flagship Journal
17 Mar 2026
MMS Throughout Pregnancy
Clinical evidence demonstrates that MMS, particularly formulations containing 800 μg folic acid, can support maternal and fetal health from..
Flagship Journal
17 Mar 2026
25 Red Flags Raising Suspicion of EGPA
A European Delphi consensus identifying 25 clinical red flags for EGPA in patients with asthma and unexplained blood eosinophilia, ranked…
Hematology
12 Mar 2026
Revisiting Erythroid Response to Luspatercept in the Phase III BELIEVE Trial Using Real-World Response Criteria
Patients with TDT have impaired erythropoiesis and face a chronic treatment burden of regular transfusions and iron chelation therapy to…
Neurology
5 Mar 2026
Revealing the Pathophysiology Behind CIDP
Explore the pathophysiology behind chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), understanding the disease’s…
Loading posts...
« Previous
1
2
3
4
5
6
…
21
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View